" 600.13 
retention samples. 
manufacturers shall retain for a period of at least 6 months after the expiration date, unless a different time period is specified in additional standards, a quantity of representative material of each lot of each product, sufficient for examination and testing for safety and potency, except whole blood, cryoprecipitated ahf, platelets, red blood cells, plasma, and source plasma and allergenic products prepared to a physician's prescription. samples so retained shall be selected at random from either final container material, or from bulk and final containers, provided they include at least one final container as a final package, or package-equivalent of such filling of each lot of the product as intended for distribution. such sample material shall be stored at temperatures and under conditions which will maintain the identity and integrity of the product. samples retained as required in this section shall be in addition to samples of specific products required to be submitted to the center for biologics evaluation and research or the center for drug evaluation and research (see mailing addresses in  600.2). exceptions may be authorized by the director, center for biologics evaluation and research or the director, center for drug evaluation and research, when the lot yields relatively few final containers and when such lots are prepared by the same method in large number and in close succession. 

